Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Medical College of Wisconsin
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
St. Jude Children's Research Hospital
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Sanofi
Institut Bergonié
Seagen Inc.
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
University of Miami
Memorial Sloan Kettering Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Virginia Commonwealth University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Polish Lymphoma Research Group
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Indiana University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center